Loading…
Based on limited metadata, this warning letter issued to CTX Lifesciences Private Ltd. on July 12, 2019 concerns drug product manufacturing or compliance. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The FDA's drug regulatory authority was engaged in this enforcement action, though the specific issuing office is not identified in the metadata provided.